Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.370
-0.050 (-3.52%)
Mar 3, 2026, 4:00 PM EST - Market closed
Organigram Global Revenue
Organigram Global had revenue of 63.54M CAD in the quarter ending December 31, 2025, with 48.70% growth. This brings the company's revenue in the last twelve months to 279.99M, up 68.55% year-over-year. In the fiscal year ending September 30, 2025, Organigram Global had annual revenue of 259.18M with 62.15% growth.
Revenue (ttm)
279.99M CAD
Revenue Growth
+68.55%
P/S Ratio
0.90
Revenue / Employee
246,254 CAD
Employees
1,137
Market Cap
184.72M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 259.18M | 99.34M | 62.15% |
| Sep 30, 2024 | 159.84M | -1.80M | -1.11% |
| Sep 30, 2023 | 161.64M | 15.83M | 10.86% |
| Aug 31, 2022 | 145.81M | 66.65M | 84.19% |
| Aug 31, 2021 | 79.16M | -7.63M | -8.79% |
| Aug 31, 2020 | 86.80M | 6.38M | 7.94% |
| Aug 31, 2019 | 80.41M | 67.98M | 546.98% |
| Aug 31, 2018 | 12.43M | -377.00K | -2.94% |
| Aug 31, 2017 | 12.81M | 550.75K | 4.49% |
| Aug 31, 2016 | 12.26M | 11.27M | 1,142.07% |
| Aug 31, 2015 | 986.68K | - | - |
| Feb 28, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organogenesis Holdings | 564.17M |
| Evolus | 285.82M |
| Aurora Cannabis | 272.13M |
| Akebia Therapeutics | 236.20M |
| Lifecore Biomedical | 128.87M |
| Anika Therapeutics | 112.82M |
| Journey Medical | 59.40M |
| Alpha Teknova | 40.52M |
OGI News
- 4 days ago - 3 Canadian Marijuana Stocks To Diversify Your Stock Portfolio - MarijuanaStocks
- 8 days ago - Organigram (OGI) Expands Product Line in Australia with New Launch - GuruFocus
- 8 days ago - Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia - Business Wire
- 12 days ago - What's Going On With Organigram Global Stock Thursday? - Benzinga
- 13 days ago - Organigram (OGI) Gains on C$65.2M Investment from British American Tobacco - GuruFocus
- 13 days ago - Organigram gets C$65.2M BAT investment for Sanity - Seeking Alpha
- 13 days ago - Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group - Business Wire
- 14 days ago - Organigram Bets Big On Europe With Sanity Group Takeover - Benzinga